Well, if the purpose in doing this is to lower the cost of the drug to the end user or the end payer, and you could get there the same way by just charging 6 percent less or giving a rebate to the physician who, I guess, keeps that, it seems to me that you are, in fact, paying that rebate to drive physicians to use your drug.
Corker argues that rebates may incentivize physicians rather than just reduce costs.
Share
More from Bob Corker
I wish to speak on S. 1862, the Trafficking Victims Protection Reauthorization Act of 2017.
This was one of the biggest foreign policy blunders that I can remember, maybe the biggest.
We need to make every dollar of our limited foreign aid resources count by addressing problems where we can have a real impact on people's lives.
I can understand from the people's perspective that are doing this why they would want to go forward. And I understand that.
Other voices in this conversation
